All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry

Aaron M Secrest, Dorothy J Becker, Sheryl F Kelsey, Ronald E LaPorte, Trevor J Orchard, Aaron M Secrest, Dorothy J Becker, Sheryl F Kelsey, Ronald E LaPorte, Trevor J Orchard

Abstract

Objective: Although management of type 1 diabetes improved dramatically in the 1980s, the effect on mortality is not clear.

Research design and methods: We report trends in 30-year mortality using the Allegheny County (Pennsylvania) childhood-onset (age <18 years) type 1 diabetes registry (n = 1,075) with diagnosis from 1965-1979, by dividing the cohort into three diagnosis year cohorts (1965-1969, 1970-1974, and 1975-1979). Local (Allegheny County) mortality data were used to calculate standardized mortality ratios (SMRs).

Results: As of 1 January 2008, vital status was ascertained for 97.0% of participants (n = 1,043) when mean age ± SD and duration of diabetes were 42.8 ± 8.0 and 32.0 ± 7.6 years, respectively. The 279 deaths (26.0%) observed were 7 times higher than expected (SMR 6.9 [95% CI 6.1-7.7]). An improving trend in SMR was seen by diagnosis cohort at 30 years of diabetes duration (9.3 [7.2-11.3], 7.5 [5.8-9.2], and 5.6 [4.0-7.2] for 1965-1969, 1970-1974, and 1975-1979, respectively). Although no sex difference in survival was observed (P = 0.27), female diabetic patients were 13 times more likely to die than age-matched women in the general population (SMR 13.2 [10.7-15.7]), much higher than the SMR for men (5.0 [4.0-6.0]). Conversely, whereas 30-year survival was significantly lower in African Americans than in Caucasians (57.2 vs. 82.7%, respectively; P < 0.001), no differences in SMR were seen by race.

Conclusions: Although survival has clearly improved, those with diabetes diagnosed most recently (1975-1979) still had a mortality rate 5.6 times higher than that seen in the general population, revealing a continuing need for improvements in treatment and care, particularly for women and African Americans with type 1 diabetes.

Figures

Figure 1
Figure 1
Life-table analyses by sex (A), race (B), diagnosis cohort (C), and age at onset (D) for individuals with type 1 diabetes between 1965 and 1979 in the Allegheny County type 1 diabetes registry cohort. P values calculated using the log-rank test. C: 1965–1969 vs. 1970–1974, P = 0.02, and 1965–1969 vs. 1975–1979, P = 0.02. D: <10 vs. 10–14 years, P = 0.002, and <10 vs. >14 years, P < 0.001.
Figure 2
Figure 2
SMRs and 95% CIs for the overall (A) Allegheny County Type 1 Diabetes Registry cohort and by sex (B), race (C), and diagnosis cohort (D) at 5-year intervals of follow-up. C and D are spaced around the 5-year intervals for visual clarity; however, all SMRs are calculated at the same 5-year follow-up points.

References

    1. Shankar A, Klein R, Klein BE, Moss SE: Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes. Am J Epidemiol 2007;166:393–402
    1. Goldstein DE, Walker B, Rawlings SS, Hess RL, England JD, Peth SB, Hewett JE: Hemoglobin A1c levels in children and adolescents with diabetes mellitus. Diabetes Care 1980;3:503–507
    1. Consensus statement on self-monitoring of blood glucose. Diabetes Care 1987;10:95–99
    1. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329:1456–1462
    1. Asao K, Sarti C, Forsen T, Hyttinen V, Nishimura R, Matsushima M, Reunanen A, Tuomilehto J, Tajima N: Diabetes Epidemiology Research International Mortality Study Group Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care 2003;26:2037–2042
    1. Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G: Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006;49:298–305
    1. Nishimura R, LaPorte RE, Dorman JS, Tajima N, Becker D, Orchard TJ: Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965–1999. Diabetes Care 2001;24:823–827
    1. LaPorte RE, Fishbein HA, Drash AL, Kuller LH, Schneider BB, Orchard TJ, Wagener DK: The Pittsburgh insulin-dependent diabetes mellitus (IDDM) registry. The incidence of insulin-dependent diabetes mellitus in Allegheny County, Pennsylvania (1965–1976). Diabetes 1981;30:279–284
    1. Major cross-country differences in risk of dying for people with IDDM. Diabetes Epidemiology Research International Mortality Study Group. Diabetes Care 1991;14:49–54
    1. International evaluation of cause-specific mortality and IDDM. Diabetes Epidemiology Research International Mortality Study Group. Diabetes Care 1991;14:55–60
    1. International analysis of insulin-dependent diabetes mellitus mortality: a preventable mortality perspective. The Diabetes Epidemiology Research International (DERI) Study. Am J Epidemiol 1995;142:612–618
    1. EpiQMS—Epidemiologic Query and Mapping System Bureau of Health Statistics, Pennsylvania Department of Health [available online], 2010. Available from Accessed 17 March 2010
    1. Armstrong BG: Comparing standardized mortality ratios. Ann Epidemiol 1995;5:60–64
    1. Dawson SI, Willis J, Florkowski CM, Scott RS: All-cause mortality in insulin-treated diabetic patients: a 20-year follow-up. Diabetes Res Clin Pract 2008;80:e6–e9
    1. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, Smith AW, Hill RD, Bingley PJ, Patterson CC, Qiao Z, Keen H: The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999;16:459–465
    1. Patterson CC, Dahlquist G, Harjutsalo V, Joner G, Feltbower RG, Svensson J, Schober E, Gyürüs E, Castell C, Urbonaité B, Rosenbauer J, Iotova V, Thorsson AV, Soltész G: Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetologia 2007;50:2439–2442
    1. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM: All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia 2006;49:660–666
    1. Waernbaum I, Blohmé G, Ostman J, Sundkvist G, Eriksson JW, Arnqvist HJ, Bolinder J, Nyström L: Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden. Diabetologia 2006;49:653–659
    1. Walsh MG, Zgibor J, Songer T, Borch-Johnsen K, Orchard TJ: DiaComp Investigators The socioeconomic correlates of global complication prevalence in type 1 diabetes (T1D): a multinational comparison. Diabetes Res Clin Pract 2005;70:143–150
    1. Hu G, Baker SP: Reducing black/white disparity: changes in injury mortality in the 15–24 year age group, United States, 1999–2005. Inj Prev 2008;14:205–208
    1. Roy M, Rendas-Baum R, Skurnick J: Mortality in African-Americans with type 1 diabetes: The New Jersey 725. Diabet Med 2006;23:698–706
    1. McNally PG, Raymond NT, Burden ML, Burton PR, Botha JL, Swift PG, Burden AC, Hearnshaw JR: Trends in mortality of childhood-onset insulin-dependent diabetes mellitus in Leicestershire: 1940–1991. Diabet Med 1995;12:961–966
    1. Borch-Johnsen K: Improving prognosis of type 1 diabetes. Mortality, accidents, and impact on insurance. Diabetes Care 1999;22(Suppl. 2):B1–B3
    1. Sartor G, Dahlquist G: Short-term mortality in childhood onset insulin-dependent diabetes mellitus: a high frequency of unexpected deaths in bed. Diabet Med 1995;12:607–611

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren